Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.


Delayed Data
As of 3:58pm ET
 +0.05 / +12.50%
Today’s Change
Today|||52-Week Range
Key FDA Events to Watch Out for in Q1
9:06am / Zacks.com - Paid Partner Content
2 Top Stocks in Biotech
Jan 09 / MotleyFool.com - Paid Partner Content
David Herro's Oakmark International Fund Fourth Quarter Letter
Jan 11 / GuruFocus News - Paid Partner Content
Why Biotech Titans Are Clashing Over Cholesterol
Jan 08 / MotleyFool.com - Paid Partner Content
Sanofi, ImmuNext Ink Deal, Focus on Autoimmune Diseases
Jan 11 / Zacks.com - Paid Partner Content
Better Buy: Regeneron Pharmaceuticals, Inc. vs. Pfizer
Jan 07 / MotleyFool.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Clovis Oncology, Pfizer, Roche's, Sanofi and Regen...
Jan 10 / Zacks.com - Paid Partner Content
Amgen's Repatha Wins Over Sanofi & Regeneron's Praluent
Jan 06 / Zacks.com - Paid Partner Content
Amgen Inks Multiple Deals, Offers Update on Repatha Lawsuit
Jan 10 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: PCSK9 Inhibitor Praluent in News, Allergan's Preliminary 2017 V...
Jan 06 / Zacks.com - Paid Partner Content
Biotech Resolutions: More Innovation, Better Execution, and Fewer Price Hikes
Jan 10 / MotleyFool.com - Paid Partner Content
Obama's final jobs report; Trump hits Toyota; Indian GDP forecast
Jan 06 / CNNMoney.com
The FDA Approved Fewer Drugs in 2016: Here's Why
Jan 09 / Zacks.com - Paid Partner Content
How Risky Is Inovio Pharmaceuticals, Inc.?
Jan 05 / MotleyFool.com - Paid Partner Content
Impax (IPXL) Applies for Generic Aubagio; Sanofi Files Lawsuit
Jan 09 / Zacks.com - Paid Partner Content
Eli Lilly Acquires Boehringer Ingelheim's Pet Vaccines Unit
Jan 04 / Zacks.com - Paid Partner Content